Here in hepatocellular carcinoma, we used in vivo experiments to demonstrate that cancer cells express Esm1 to inhibit CD4+T cells mediated cancer cytotoxicity, which supports the anti-inflammatory role of ESM1 in HCC development. Here, CD4 is linked to cancer.